1% and probability of survival without reoperation for cusp failure after 10 years was 80%.6 Degenerative lesions leading to stenosis or regurgitation related to geometric distortion of the aortic homograft are rare long term problems.67 Although an infection may destroy the aortic homograft, this complication seems to be less frequent than after prosthetic valve replacement.6 89 Aortic valve replacement and aortic root reconstruction with a composite tube-valve homograft is recommended as first choice treatment in patients with acute endocarditis with or without aortic root destruction or annular abscess; it is associated with a lower incidence of recurrent infection than mechanical or bioprosthesis. [1][2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Moreover, aortic homograft implantation is considered to be the treatment of first choice in patients with contraindications for mechanical prosthesis or in whom long term anticoagulation is undesirable.6 12 13
Since the introduction of homograft for aortic valve surgery by Ross' and Barratt-Boyes,2 aortic valve replacement and aortic root reconstruction with this material has become a well accepted surgical method of treating endocarditis and its complications, with long term results as good as or better than bioprostheSiS.-35 Excellent results in isolated primary aortic valve replacement with a homograft have been reported recently; hospital mortality was 1% and probability of survival without reoperation for cusp failure after 10 years was 80%.6 Degenerative lesions leading to stenosis or regurgitation related to geometric distortion of the aortic homograft are rare long term problems.67 Although an infection may destroy the aortic homograft, this complication seems to be less frequent than after prosthetic valve replacement.6 89 Aortic valve replacement and aortic root reconstruction with a composite tube-valve homograft is recommended as first choice treatment in patients with acute endocarditis with or without aortic root destruction or annular abscess; it is associated with a lower incidence of recurrent infection than mechanical or bioprosthesis. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Moreover, aortic homograft implantation is considered to be the treatment of first choice in patients with contraindications for mechanical prosthesis or in whom long term anticoagulation is undesirable. 6 12 13 Pseudoaneurysm development after composite graft replacement of the aortic valve and the ascending aorta is a well described complication.'1'6 In contrast, there are only a few reports describing pseudoaneurysms after homograft implantation.6 1718 We decided to assess systematically the incidence and predisposing factors for pseudoaneurysm formation after detection of a perfused echo-free space between the aortic homograft and the native aortic wall during routine postoperative Doppler echocardiography. All patients except one were examined by transthoracic cross sectional Doppler echocardiography; one intensive care patient was investigated by transoesophageal echocardiography.
Indications for insertion of an aortic homograft were active endocarditis (n = 15) at time of surgery, 12 with abscess formation, two with infected aortic valves, and one with a paravalvular leak. Seven patients had a history of previously cured endocarditis: three had a perfused abscess cavity, three a paravalvular leak, and one a perforated cusp after eradication of endocarditis. Anticoagulation was undesirable in eight patients without any history of endocarditis.
DEFINITION OF PSEUDOANEURYSM
Aortic homograft pseudoaneurysm was defined as a perfused echo-free space between the native aortic wall and the aortic homograft due to partial dehiscence at the proximal suture line (figs [1] [2] [3] . Communication between this space and the left ventricular outflow tract needed a systo-diastolic colour Doppler signal for visualisation. Typically, the onset of this signal within the echo-free space occurred before the onset of the systolic colour Doppler signal within the aortic homograft (fig 4) .
OPERATING TECHNIQUES
Cardiopulmonary bypass was conducted in moderate hypothermia through aorto-atrial cannulation. Usually, myocardial protection was performed by continuous retrograde cold blood cardioplegia. Exposure of the oblique aortotomy was facilitated by placement of three stay sutures. After preparation of the cryopreserved allograft and resection of the native valve, the proximal suture line was performed in a continuous or interrupted manner with a polypropylene monofilament. During construction of the proximal suture, the homograft was inverted into the left ventricle. Positional traction sutures of 4 0 monofilament were placed at the top of each commissure to maintain optimal suspension. Starting at the bottom of each coronary sinus, the suture runs to the tops of each commissure, where it is brought outside the native aorta. The sutures were tied over pledgets outside the aorta. Aortic homograft was implanted as aortic valve replacement in this classic technique (type I), as aortic root reconstruction with infracoronary anastomosis of the homograft ( A 39 year old man developed recurrent endocarditis two months after implantation of an aortic homograft (because of CarpentierEdwards bioprosthetic endocarditis with S aureus), with rupture of the cusp situated at the site of the right coronary sinus and perforation of the aortic annulus at the site of the non-coronary sinus causing a shunt to the left atrium. Antibiotic treatment was given for six weeks and the aortic homograft was then replaced by a new one (diameter 21 mm), 3-5 months after the previous homograft implantation. Early in the postoperative period, Doppler echocardiographic examination showed a large pseudoaneurysm at the site of the right coronary sinus, with severe haemodynamic impairment (mean systolic transvalvular aortic gradient = 50 mm Hg). A further operation was immediately performed, with refixation of the homograft at the proximal anastomosis. Fibrin glue was used to close the prior abscess cavity. A small pseudoaneurysm was present at the site of the same coronary sinus after refixation of the aortic homograft. Discussion Thirty years after the first description of the use of an aortic homograft by Ross and Barratt-Boyes," 2 the method has become increasingly popular because of its increased availability, improved preparation, storage and surgical techniques, and good long term results.346 Degenerative lesions or infectious complications rarely seem to be a problem after homograft aortic valve replacement or aortic root reconstruction.56 Although homografts are used more often, the majority of our patients underwent prosthetic valve replacement. Thus overall 732 aortic valve replacements were performed during the study period at our institution, including patients with additional cardiovascular surgery (mitral valve reconstruction or replacement, composite graft implantation, coronary bypass grafting), and only 30 patients (age > 16 years) received aortic homograft implantation.
Interestingly, perfused echo-free spaces between the aortic homograft and the native aortic wall, that is, pseudoaneurysm formation, have not been reported so far as a common postoperative Doppler echocardiographic finding and a source of potential complications. In contrast, in 22 of our 30 patients (73%) a pseudoaneurysm situated at the level of the aortic root was found after aortic valve replacement with a homograft. Florid infection at the time of operation or a paravalvular leak after eradicated infection did not influence the formation of pseudoaneurysms; however, the location of the pseudoaneurysm corresponded with the location of abscesses or paravalvular leaks in 14 of 16 cases. This interesting observation might be explained by severe tissue disturbance at the level of the aortic annulus and beneath, thus complicating the setting of sutures. Similar conditions can be found in patients with a previous aortic valve operation resulting in a slightly, but not significantly, higher probability of developing a pseudoaneurysm. Neither the operating technique (annular, infra-annular, or tube-valve homograft) nor the type of proximal suture line (continuous/interrupted) influenced the development of a pseudoaneurysm. Moreover, pseudoaneurysms could already be detected a few days after homograft implantation in the majority of our patients.
The mean Doppler echocardiographic systolic transvalvular pressure gradient was slightly, but not significantly, higher in patients with a pseudoaneurysm (15 mm Hg v 10 mm Hg) despite similar homograft diameters (23 mm v 22 mm) in both groups (with and without a pseudoaneurysm). This slightly higher systolic pressure gradient in patients with a pseudoaneurysm might be caused by homograft compression because of inflation of the echo-free space by blood; the higher pressure gradient may also reflect the higher blood flow through the aortic valve because of the presence of moderate aortic regurgitation in three patients with a pseudoaneurysm compared to only mild regurgitation in patients without a pseudoaneurysm. Left ventricular function may be considered as a further factor influencing the transvalvular pressure gradient.
In our series, the incidence of mild (27/30) and moderate (3/30) aortic regurgitation was higher than that reported by Kirklin et al, who found an initial (within one month) postoperative incidence of mild and moderate insufficiency of only 37% and 4%, respectively; 59% of the operated patients had no aortic regurgitation on the initial Doppler echocardiogram.6
The mean pressure gradient of 14 (11) mm Hg in 27 patients (mean pressure gradient was not available in three patients) was higher than the gradient reported by Jaffe and coworkers in 27 normally functioning homografts 7 (3) mm Hg. 22 The lower mean pressure gradient in the report of Jaffe might be explained partly by the small number of patients in both series, or by the homograft size (12 
CONCLUSIONS
When carefully looked for pseudoaneurysm formation appears to be a common postoperative finding after aortic valve replacement with a homograft, especially at the site of an abscess or a paravalvular leak after eradication of a prosthetic valve endocarditis.
Clinically the most significant complication in our study was compression of the homograft with obstruction of the aortic valve area in one patient. However, it is conceivable that pseudoaneurysm formation may cause additional stress at the suture line and the aortic wall with the potential risk of rupture, embolisation, and newly acquired or recurrent infection. A prospective study is necessary to determine the prognostic importance and the risks associated with pseudoaneurysm formation. Finally, modification of the surgical technique (for example, sealing the native aortic wall and the aortic homograft by application of fibrin glue between the two structures)'9 may reduce the risk of dehiscence of the proximal suture line and pseudoaneurysm development.
